glp-1 weight loss manhattan Medications in Lower Manhattan, NY GLP-1 for New York, NY
Description
Victoza contains liraglutide and should not be coadministered with other liraglutide-containing products Indications and Limitations of Use Victoza (liraglutide) injection 1.2 mg or 1.8 mg is indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes and to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with type 2 diabetes and established cardiovascular disease
/assets/production/practices/6c772b9038ae2abc9c8366c7de24e78e28ea6cab/images/2814250.jpg)
A 2024 study published in JAMA Ophthalmology found that patients prescribed semaglutide had a higher observed risk of NAION compared with patients using non-GLP-1 medications for diabetes or weight loss

its an essential part of our holistic, personalized approach to wellness

Side effects on Wegovy that are likely to recur on Zepbound
For detailed comparison of these medication options, see our Zepbound vs Wegovy guide

And unlike older weight-loss products that relied on stimulants or harsh chemicals, this one takes a more measured, natural approach